- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Bedroom Shoppers
Hong Kong Pharmaceuticals & Biotech Bedroom Shoppers
UPDATED Sep 16, 2023
Online and catalog retail companies worldwide.
96 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 6118Austar Lifesciences | HK$2.04 | 0% | 16.6% | HK$1.0b | n/a | PE580.6x | n/a | 0% | ||
| 2126JW (Cayman) Therapeutics | HK$2.03 | -9.4% | -45.0% | HK$813.5m | HK$3.49 | PS4.5x | E26.0% | n/a | ||
| 950Lee's Pharmaceutical Holdings | HK$1.34 | 10.7% | -27.6% | HK$789.0m | HK$1.10 | PE20.3x | S16.4% | 1.2% | ||
| 6996Antengene | HK$1.14 | -10.9% | -69.2% | HK$769.4m | HK$4.57 | PS4x | E15.3% | n/a | ||
| 8049Jilin Province Huinan Changlong Bio-pharmacy | HK$1.34 | -0.7% | 24.1% | HK$750.7m | n/a | PE3.5x | n/a | 40.1% | ||
| 2161JBM (Healthcare) | HK$0.82 | -11.8% | -2.4% | HK$730.8m | n/a | PE12.8x | n/a | 3.7% | ||
| 1228CANbridge Pharmaceuticals | HK$1.47 | -2.0% | -54.1% | HK$623.9m | HK$1.70 | PS6.6x | E19.7% | n/a | ||
| 6998Genor Biopharma Holdings | HK$1.22 | -12.2% | -49.2% | HK$613.2m | n/a | PS43.9x | n/a | n/a | ||
| 503Lansen Pharmaceutical Holdings | HK$1.42 | 0% | 32.5% | HK$595.4m | n/a | PE10.3x | n/a | 3.4% | ||
| 239Pak Fah Yeow International | HK$1.78 | -1.1% | 45.9% | HK$554.7m | n/a | PE6.3x | n/a | 6.9% | ||
| 897Wai Yuen Tong Medicine Holdings | HK$0.39 | -3.8% | 4.1% | HK$450.9m | n/a | PB0.2x | n/a | 0% | ||
| 1498PuraPharm | HK$1.12 | 12.0% | 9.8% | HK$442.5m | n/a | PS1.1x | n/a | 0% | ||
| 455Tianda Pharmaceuticals | HK$0.20 | -4.9% | 18.2% | HK$419.3m | n/a | PB0.7x | n/a | 1.3% | ||
| 690Uni-Bio Science Group | HK$0.057 | 1.8% | -35.2% | HK$362.8m | n/a | PE5.7x | n/a | n/a | ||
| 8329Shenzhen Neptunus Interlong Bio-technique | HK$0.16 | 1.3% | 8.7% | HK$271.8m | n/a | PE4x | n/a | n/a | ||
| 1643Modern Chinese Medicine Group | HK$0.42 | -8.7% | -5.6% | HK$252.0m | n/a | PE3.6x | n/a | 0% | ||
| 8158China Regenerative Medicine International | HK$0.85 | -5.6% | -48.8% | HK$242.6m | n/a | PE16.1x | n/a | n/a | ||
| 575Regent Pacific Group | HK$0.99 | -1.0% | -56.6% | HK$226.1m | n/a | PB2.5x | n/a | n/a | ||
| 1312Kontafarma China Holdings | HK$0.039 | 0% | 2.6% | HK$218.0m | n/a | PE40.3x | n/a | 0% | ||
| 1889Sanai Health Industry Group | HK$0.06 | -7.7% | -22.1% | HK$192.6m | n/a | PE4.9x | n/a | 0% | ||
| 1011China NT Pharma Group | HK$0.067 | 4.7% | -36.2% | HK$159.3m | n/a | PE-3.4x | n/a | 0% | ||
| 8225China Health Group | HK$0.16 | -12.3% | -43.9% | HK$156.3m | n/a | PB1x | n/a | n/a | ||
| 858Extrawell Pharmaceutical Holdings | HK$0.053 | 10.4% | -31.2% | HK$126.7m | n/a | PE1x | n/a | n/a | ||
| 8247Biosino Bio-Technology and Science Incorporation | HK$0.62 | -10.1% | -55.7% | HK$89.7m | n/a | PE39.6x | n/a | 0% |